Concepedia

Author

Antti Jekunen

Helsinki University HospitalORCID

Also Known As

A Jekunen, A P Jekunen, A. JEKUNEN, A. Jekunen, A. P. Jekunen, A.P. Jekunen, ANTTI JEKUNEN, ANTTI P. JEKUNEN, Antti Jekunen, Antti P Jekunen

138

Publications

2.2K

Citations

27

H-Index

73

Concepts

All Affiliations

Helsinki University HospitalUniversity of HelsinkiVaasa Central HospitalKuopio University HospitalUniversity of California San Diego
AJ

About

Antti Jekunen is an author at Helsinki University Hospital specializing in medicine, oncology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

17

19

779

2

Health Sciences

4

4

153

3

Arts

1

1

19

4

Engineering

1

1

135

5

Natural Sciences

1

1

17

Antti Jekunen

×

44

Publications

1.6K

Citations

23

H-Index

YearCitations

Endoglin is a suitable target for efficient imaging of solid tumors: in vivo evidence in a canine mammary carcinoma model.

Ester Fonsatti, Antti Jekunen, Kalevi Kairemo,

PubMed

2000

135

Enhanced expression of the tie receptor tyrosine kinase mesenger RNA in the vascular endothelium of metastatic melanomas.

Arja Kaipainen, Tatyana Vlaykova, E Hatva,

PubMed

1994

112

Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study

Pia Österlund, Tapio K. Salminen, Leena-Maija Soveri,

The Lancet Regional Health - Europe

2021

104

Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: a prospective randomized study

Tuula A. Makkonen, Heikki Minn, Antti Jekunen,

International Journal of Radiation Oncology*Biology*Physics

2000

86

Prognostic value of tumour vascularity in metastatic melanoma and association of blood vessel density with vascular endothelial growth factor expression

Tatyana Vlaykova, P Laurila, Timo Muhonen,

Melanoma Research

1999

71

Treatment of Acute Low Back Pain With the COX-2–Selective Anti-Inflammatory Drug Nimesulide

Timo Pohjolainen, Antti Jekunen, Lotta Autio,

Spine

2000

67

Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study

Joyce O’Shaughnessy, Susana Sousa, Josefina Cruz,

European Journal of Cancer

2021

67

Comparative genomic hybridization analysis of chromosomal changes occurring during development of acquired resistance to cisplatin in human ovarian carcinoma cells

Vell-Matti Wasenius, Antti Jekunen, Outi Monni,

Genes Chromosomes and Cancer

1997

62

In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacologic alteration of microtubules.

R D Christen, Antti Jekunen, Jeffrey A. Jones,

Journal of Clinical Investigation

1993

54

Phase I and Pharmacokinetic Study of the Dolastatin-15 Analogue Tasidotin (ILX651) Administered Intravenously on Days 1, 3, and 5 Every 3 Weeks in Patients with Advanced Solid Tumors

Casey Cunningham, Leonard J. Appleman, David P. Ryan,

Clinical Cancer Research

2005

51

Page 1